Launching a Health Report for Male Pattern Baldness (MPHL)
Team Genomes are excited to announce the launch of a Male-pattern Baldness (androgenic alopecia) health report on our infrastructure, providing our vault holders with crucial insight into their genome.
Male pattern baldness is one of the most common hair loss conditions, affecting approximately 85% of all men by the time they reach the age of 50.
Symptoms can include hair thinning or loss on the crown, near the temples, and a receding hairline. A receding hairline typically resembles an “M” shape. As hair loss progresses, thinning at the crown and temples may eventually connect, creating a “U” shape.
While it often begins in the late 20s or early 30s, hair loss can start as early as your teens and progress over time.
You can read more about the condition here.
Why are we doing this?
With these reports it is our goal to provide our users with crucial insights about their health using genomic data so they can better understand who they are and act effectively to live a long, healthy and happy life.
One of our other aims at Genomes is to safely and equitably contribute to scientific research that benefits the future health of all of us. We are very happy to be working towards this through our health reports. We invite you to embark on this exciting journey with us!
IMPORTANT NOTE: The information provided in our report is genotypic, and is not intended as medical advice or as a diagnosis. If you have any concerns based on the results, we strongly recommend consulting a medical professional who can provide the appropriate guidance and support.
How the report works
Our reports make use of Genome Wide Association studies (GWAS) which compare affected individuals against unaffected individuals in order to identify susceptibility genes. The data from GWAS studies allow us to calculate a polygenic risk score based on your sequenced genome.
The GWAS studies work by examining Single Nucleotide Polymorphisms (SNPs), which are a single base pair change in your DNA sequence. These act as genetic markers, which can be seen in affected individuals and associated with nearby genes. Once there has been association made this can be further examined by looking on online databases, allowing the confirmation of it being a risk or susceptibility gene.
The test will show you a polygenic risk score, which allows you to see the risk of developing the disease based on your genetic variations. No raw data will ever leave your vault, with the reports being generated within your web account.
To run your test and get your personalised results, head over to your dashboard at Genomes.io.
As always, feel free to connect with us via info@genomes.io should you have any further questions. We are happy to help wherever we can.
A $GENOME future is now. Join us!
